X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (40) 40
humans (39) 39
male (36) 36
female (34) 34
middle aged (23) 23
taiwan (21) 21
adult (20) 20
gastroenterology & hepatology (20) 20
adolescent (14) 14
aged (14) 14
hepatitis b virus (13) 13
prevalence (13) 13
hepatitis b (12) 12
virus-infection (12) 12
hepatocellular-carcinoma (11) 11
infection (11) 11
taiwan - epidemiology (11) 11
vaccination (11) 11
children (9) 9
confidence intervals (9) 9
hepatitis (9) 9
multivariate analysis (9) 9
retrospective studies (9) 9
risk factors (9) 9
case-control studies (8) 8
disease (8) 8
follow-up (8) 8
hepatocellular carcinoma (8) 8
mass vaccination (8) 8
medicine (8) 8
medicine, general & internal (8) 8
antigens (7) 7
cirrhosis (7) 7
hepatitis b vaccines - immunology (7) 7
internal medicine (7) 7
therapy (7) 7
analysis (6) 6
association (6) 6
care and treatment (6) 6
entecavir (6) 6
health aspects (6) 6
hepatitis b - prevention & control (6) 6
hepatitis b antibodies - blood (6) 6
hepatitis b surface antigens - blood (6) 6
hepatitis c virus (6) 6
risk (6) 6
risk-factors (6) 6
time factors (6) 6
age (5) 5
alanine transaminase - blood (5) 5
antiviral agents - therapeutic use (5) 5
dna, viral - blood (5) 5
follow-up studies (5) 5
hepatitis b - epidemiology (5) 5
hepatitis b, chronic - drug therapy (5) 5
hepatology (5) 5
immunization, secondary (5) 5
infections (5) 5
interferon (5) 5
lamivudine (5) 5
medicine, research & experimental (5) 5
metabolic syndrome (5) 5
odds ratio (5) 5
viral load (5) 5
virology (5) 5
young adult (5) 5
complications and side effects (4) 4
digestive system diseases (4) 4
epidemiology (4) 4
fibrosis (4) 4
gastroesophageal reflux disease (4) 4
guanine - analogs & derivatives (4) 4
hbsag (4) 4
hbv (4) 4
hepatitis b e antigen (4) 4
hepatitis b e antigens - blood (4) 4
hepatitis b surface antigens - immunology (4) 4
hepatitis b vaccines - administration & dosage (4) 4
hepatitis c (4) 4
hepatitis c, chronic - complications (4) 4
hepatitis c, chronic - drug therapy (4) 4
hla (4) 4
liver cancer (4) 4
management (4) 4
medicine & public health (4) 4
population (4) 4
severity of illness index (4) 4
sex factors (4) 4
smoking (4) 4
surgery (4) 4
survival (4) 4
teenagers (4) 4
treatment outcome (4) 4
age factors (3) 3
alanine aminotransferase (3) 3
alpha (3) 3
cancer (3) 3
carcinoma, hepatocellular - pathology (3) 3
carcinoma, hepatocellular - virology (3) 3
chronic infection (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Hepatology, ISSN 0270-9139, 01/2014, Volume 59, Issue 1, pp. 349 - 350
Journal Article
Hepatology, ISSN 0270-9139, 01/2014, Volume 59, Issue 1, p. 349
Journal Article
Hepatology, ISSN 0270-9139, 01/2014, Volume 59, Issue 1, pp. 349 - 350
Journal Article
Hepatology, ISSN 0270-9139, 01/2014, Volume 59, Issue 1, pp. 349 - 350
Journal Article
Vaccine, 09/2019
No report explored the combined effects of HLA-DPA1 and -DPB1 with long-term response to hepatitis B (HB) vaccination (HBVac). The specific aims of the study... 
Journal Article
Journal of Gastroenterology and Hepatology, ISSN 0815-9319, 02/2014, Volume 29, Issue 2, pp. 269 - 275
Journal Article
Journal of Gastroenterology and Hepatology, ISSN 0815-9319, 05/2015, Volume 30, Issue 5, pp. 891 - 899
Journal Article
Journal of Gastroenterology and Hepatology, ISSN 0815-9319, 03/2012, Volume 27, Issue 3, pp. 586 - 591
Journal Article
Hepatology, ISSN 0270-9139, 08/2015, Volume 62, Issue 2, pp. 375 - 386
Journal Article
Journal Article
Tzu Chi Medical Journal, ISSN 1016-3190, 2009, Volume 21, Issue 3, pp. 190 - 196
Colorectal cancer (CRC) was the third-leading cause of cancer death in Taiwan in 2008. The natural history of CRC provides a chance for screening and... 
Screening | Colonoscopy | Colorectal cancer | Diagnosis | Cancer | Smoking
Journal Article
European Journal of Gastroenterology & Hepatology, ISSN 0954-691X, 08/2017, Volume 29, Issue 8, pp. 946 - 950
OBJECTIVEAs the efficacy of a direct antiviral agent is reduced in cirrhotic chronic hepatitis C patients, prolonged duration of treatment or addition of... 
Cirrhosis | entecavir | hepatitis B virus | therapeutic response | FIBROSIS | EFFICACY | SAFETY | VIROLOGICAL RESPONSE | LAMIVUDINE | HEPATOCELLULAR-CARCINOMA | DECOMPENSATED CIRRHOSIS | INFECTION | UPDATE | GASTROENTEROLOGY & HEPATOLOGY | CLINICAL-PRACTICE | cirrhosis | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2013, Volume 8, Issue 7, pp. e70458 - e70458
Background: Interferon-based therapy (IBT) has been the standard of care for hepatitis C virus (HCV) infection. However, conflicting results exist regarding... 
SUSTAINED VIROLOGICAL RESPONSE | VIRUS-RELATED CIRRHOSIS | METAANALYSIS | MANAGEMENT | TAIWAN | MULTIDISCIPLINARY SCIENCES | ADVANCED FIBROSIS | ALPHA | ASIAN-PACIFIC ASSOCIATION | RIBAVIRIN THERAPY | HCV INFECTION | Liver Neoplasms - prevention & control | Recombinant Proteins - therapeutic use | Liver Cirrhosis - etiology | Liver Cirrhosis - prevention & control | Hepatitis C - drug therapy | Antiviral Agents - therapeutic use | Liver Cirrhosis - complications | Carcinoma, Hepatocellular - prevention & control | Humans | Middle Aged | Risk Factors | Interferon-alpha - therapeutic use | Hepatitis C, Chronic - complications | Hepatitis C, Chronic - drug therapy | Polyethylene Glycols - therapeutic use | Liver Neoplasms - etiology | Young Adult | Adult | Hepatitis C - complications | Aged | Carcinoma, Hepatocellular - etiology | Retrospective Studies | Cohort Studies | Infection | Complications and side effects | Care and treatment | National health insurance | Development and progression | Interferon | Hepatoma | Hepatitis C virus | Biological response modifiers | Liver cirrhosis | Risk factors | Therapy | Chronic infection | Viruses | Hepatocellular carcinoma | Infections | Bleeding | Confidence intervals | Hepatitis | Encephalopathy | Health insurance | Medical research | Adjustment | Complications | Hazards | Patients | Survival | Esophagus | Studies | Cirrhosis | Statistical models | Insurance | Hepatitis C | Ascites | Hepatic encephalopathy | Index Medicus
Journal Article
Journal Article